Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Tetracycline Hydrochloride (TC-HCl)
100%
Proliferative Vitreoretinopathy
100%
Rhegmatogenous Retinal Detachment
100%
Hazard Ratio
71%
95% Confidence Interval
57%
Low Risk
28%
Propensity Score Matching
28%
Sensitivity Analysis
28%
Non-diabetic
28%
Reoperation
28%
Active Comparator
28%
Retinal Detachment Surgery
28%
Macular Hole Retinal Detachment
28%
Tractional Retinal Detachment
28%
E-value
14%
Kaplan-Meier
14%
Retrospective Cohort Study
14%
Comorbidity
14%
Cox Proportional Hazards Model
14%
Doxycycline
14%
Positive Control
14%
Internal Validity
14%
Healthcare Utilization
14%
Laboratory Values
14%
Commercial Interests
14%
1-year Follow-up
14%
Baseline Characteristics
14%
Socioeconomic Determinants
14%
Financial Disclosure
14%
Electronic Health Records
14%
Time-to-event Analysis
14%
Unmeasured Confounding
14%
Prospective Evaluation
14%
Proprietary Interest
14%
Follow-up Duration
14%
Negative Control Outcome
14%
Exposure Definition
14%
Value-based Care
14%
Tetracycline Exposure
14%
Well-balanced
14%
Nursing and Health Professions
Vitreoretinopathy
100%
Retina Detachment
100%
Tetracycline Derivative
100%
Tetracycline
66%
Hazard Ratio
55%
Confidence Interval
44%
Propensity Score
22%
Proliferative Retinopathy
22%
Reoperation
22%
Cohort Analysis
11%
Health Care Utilization
11%
Laboratory Value
11%
Proportional Hazards Model
11%
Internal Validity
11%
Electronic Health Record
11%
Agents Acting on the Eye
11%
Doxycycline
11%
Comorbidity
11%
E-Value
11%
Medicine and Dentistry
Retinal Detachment
100%
Proliferative Vitreoretinopathy
100%
Tetracycline
66%
Hazard Ratio
55%
Reoperation
22%
Propensity Score Matching
22%
Proliferative Retinopathy
22%
Proportional Hazards Model
11%
Retrospective Cohort Study
11%
Doxycycline
11%
Agents Acting on the Eye
11%
Electronic Health Record
11%
Health Care Utilization
11%
Comorbidity
11%
E-Value
11%
Pharmacology, Toxicology and Pharmaceutical Science
Retina Detachment
100%
Tetracycline Derivative
100%
Vitreoretinopathy
100%
Tetracycline
66%
Proliferative Retinopathy
22%
Cohort Study
11%
Doxycycline
11%
Agents Acting on the Eye
11%
Comorbidity
11%
Social Sciences
Confidence Interval
100%
Propensity Score
50%
Comorbidity
25%
Outcome Measure
25%
Proportional Hazards Model
25%